Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Jensen

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Ugeskrift for Laeger|April 12, 1993
[Low molecular heparin in prevention of thrombosis in orthopedic surgery]H P Jensen, L C Borris, M R Lassen, et al.
The International Journal of Risk & Safety in Medicine|March 21, 2013
Survival in patients undergoing total hip arthroplasty in relation to thromboprophylaxis with low molecular weight heparin: a long-term follow-up studyB S Andersen, H P Jensen, L C Borris, et al.
Haemostasis|March 1, 1993
Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunctionJ V Sørensen, H P Jensen, H B Rahr, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1992
Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparinJ V Sørensen, M R Lassen, L C Borris, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1993
Haemostatic activation in patients with head injury with and without simultaneous multiple traumaJ V Sørensen, H P Jensen, H B Rahr, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysisM R Lassen, L C Borris, H M Christiansen, et al.
Thrombosis Research|July 21, 1998
Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) StudyM R Lassen, L C Borris, B S Anderson, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Ugeskrift for Laeger|April 12, 1993
[Low molecular heparin in prevention of thrombosis in orthopedic surgery]H P Jensen, L C Borris, M R Lassen, et al.
The International Journal of Risk & Safety in Medicine|March 21, 2013
Survival in patients undergoing total hip arthroplasty in relation to thromboprophylaxis with low molecular weight heparin: a long-term follow-up studyB S Andersen, H P Jensen, L C Borris, et al.
Haemostasis|March 1, 1993
Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunctionJ V Sørensen, H P Jensen, H B Rahr, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1992
Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparinJ V Sørensen, M R Lassen, L C Borris, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1993
Haemostatic activation in patients with head injury with and without simultaneous multiple traumaJ V Sørensen, H P Jensen, H B Rahr, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysisM R Lassen, L C Borris, H M Christiansen, et al.
Thrombosis Research|July 21, 1998
Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) StudyM R Lassen, L C Borris, B S Anderson, et al.
Pageof 4